Back
We have so much waiting for you at SBS 2011
27th - 31st March. Booth #1225
With five exceptional posters and an inspiring tutorial, BioFocus can demonstrate a drug discovery offering has the ability to deliver success to your therapeutic programs.
View our 5 exceptional posters
- Efficient hit finding approaches for HMTs - the key parameters (M111)
- Selective HDAC4 inhibitors as potential therapeutics for Huntington's disease (M155)
- Coupling automated electrophysiology with microfluidic perfusion to drive hit to lead and lead optimization studies for voltage- and ligand-gated ion channel targets (W528)
- Fluorescence lifetime assays - an attractive addition to the toolbox of fragment screening technologies (T307)
- EpiRoadmap: Integration of chemogenomics-based approaches for epigenetic targets (M200)
The proposed poster "Kinetic binding studies on the muscarinic M3 receptor using the Tag Lite platform", will now be covered in the CisBio tutorial on Wednesday 30th at 12:30 - 1: 25 pm. The subject can also be discussed with BioFocus at booth #1225.
Inspiring epigenetics tutorial
Epigenetics drug discovery: success delivered by BioFocus
Wednesday 30th, 8:00 – 8:50 am. Room Osceola 1/2
Presented by Doris Hafenbradl, Senior Director, BioFocus, Switzerland
BioFocus has identified novel chemotypes that have progressed into further optimization using intelligent high-throughput screening. The epigenetics drug discovery toolbox has been significantly expanded by:
- Design of efficient and selective inhibitors of HMTs using proprietary chemogenomics tools
- Hit characterization and selectivity profiling by orthogonal assay technologies
To find out more visit us at booth #1225
Print to HTML
Print as PDF
Send to a friend